BioImagene, Inc. CEO, Dr. Ajit Singh, Speaks On Enabling Personalized Medicine Through Digital Pathology

CUPERTINO, Calif.--(BUSINESS WIRE)--Dr. Ajit Singh, CEO of BioImagene, spoke yesterday on the importance of digital pathology in personalized medicine - a rapidly emerging field that promises to tailor diagnoses and therapies for individual patients based on their specific profiles. Dr. Singh was speaking on the occasion of the California Society of Pathologists (CSP) Annual Meeting in Los Angeles, CA.

MORE ON THIS TOPIC